Xponance, Inc. Guardant Health, Inc. Transaction History

Xponance, Inc.

$10.7 Billion
Q4 2024

A detailed history of Xponance, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 8,534 shares of GH stock, worth $383,773. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,534

Holding current value

$383,773

% of portfolio

0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$20.2 - $38.11 $172,386 - $325,230	8,534 New	8,534 $260,000
Q2 2024 Aug 14, 2024	BUY	$16.07 - $31.84 $120,187 - $238,131	7,479 New	7,479 $215,000
Q2 2023 Jul 13, 2023	SELL	$20.94 - $38.01 $145,595 - $264,283	-6,953 Reduced 51.51%	6,545 $234,000
Q1 2023 Apr 17, 2023	BUY	$22.92 - $33.76 $10,566 - $15,563	461 Added 3.54%	13,498 $316,000
Q4 2022 Jan 23, 2023	BUY	$25.44 - $59.78 $35,565 - $83,572	1,398 Added 12.01%	13,037 $0
Q3 2022 Oct 24, 2022	BUY	$43.66 - $61.0 $11,744 - $16,409	269 Added 2.37%	11,639 $627,000
Q2 2022 Aug 02, 2022	BUY	$28.82 - $77.35 $30,289 - $81,294	1,051 Added 10.19%	11,370 $459,000
Q1 2022 Apr 20, 2022	BUY	$48.25 - $100.49 $9,167 - $19,093	190 Added 1.88%	10,319 $684,000
Q4 2021 Jan 31, 2022	BUY	$88.71 - $120.43 $266 - $361	3 Added 0.03%	10,129 $1.01 Million
Q3 2021 Nov 05, 2021	SELL	$98.77 - $132.17 $19,260 - $25,773	-195 Reduced 1.89%	10,126 $1.27 Million
Q2 2021 Aug 12, 2021	BUY	$109.77 - $165.68 $201,647 - $304,354	1,837 Added 21.65%	10,321 $1.28 Million
Q1 2021 May 10, 2021	SELL	$127.04 - $179.1 $5,462 - $7,701	-43 Reduced 0.5%	8,484 $1.3 Million
Q4 2020 Feb 11, 2021	BUY	$99.96 - $135.93 $79,168 - $107,656	792 Added 10.24%	8,527 $1.1 Million
Q3 2020 Oct 26, 2020	SELL	$80.32 - $111.8 $2,570 - $3,577	-32 Reduced 0.41%	7,735 $865,000
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $469,825 - $757,282	7,767 New	7,767 $630,000

Others Institutions Holding GH

# of Institutions

352

Shares Held

115M

Call Options Held

793K

Put Options Held

1.85M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.6B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account